[HTML][HTML] Clinical decision support systems for improving diagnostic accuracy and achieving precision medicine

C Castaneda, K Nalley, C Mannion… - Journal of clinical …, 2015 - Springer
As research laboratories and clinics collaborate to achieve precision medicine, both
communities are required to understand mandated electronic health/medical record …

[PDF][PDF] Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries

SL Goldberg, E Chen, M Corral, A Guo, N Mody-Patel… - J Clin Oncol, 2010 - academia.edu
Incidence and Clinical Complications of Myelodysplastic Syndromes Among United States
Medicare Beneficiaries Page 1 Incidence and Clinical Complications of Myelodysplastic …

[HTML][HTML] Protein calorie malnutrition, nutritional intervention and personalized cancer care

A Gangadharan, SE Choi, A Hassan, NM Ayoub… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Cancer patients often experience weight loss caused by protein calorie malnutrition (PCM)
during the course of the disease or treatment. PCM is expressed as severe if the patient has …

[HTML][HTML] Combination dabrafenib and trametinib versus combination nivolumab and ipilimumab for patients with advanced BRAF-mutant melanoma: the DREAMseq …

MB Atkins, SJ Lee, B Chmielowski… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
PURPOSE Combination programmed cell death protein 1/cytotoxic T-cell lymphocyte-4–
blockade and dual BRAF/MEK inhibition have each shown significant clinical benefit in …

[HTML][HTML] Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study

N Biran, A Ip, J Ahn, RC Go, S Wang… - The Lancet …, 2020 - thelancet.com
Background Tocilizumab, a monoclonal antibody directed against the interleukin-6 receptor,
has been proposed to mitigate the cytokine storm syndrome associated with severe COVID …

[PDF][PDF] Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers

AL Pecora, N Rizvi, GI Cohen, NJ Meropol… - Journal of Clinical …, 2002 - Citeseer
Patients and Methods: Seventy-nine patients with advanced solid cancers that were
unresponsive to standard therapy were enrolled. Four PV701 intravenous dosing regimens …

Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets

C Sportès, FT Hakim, SA Memon, H Zhang… - The Journal of …, 2008 - rupress.org
Interleukin-7 (IL-7) is a homeostatic cytokine for resting T cells with increasing serum and
tissue levels during T cell depletion. In preclinical studies, IL-7 therapy exerts marked …

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma

K Van Besien, FR Loberiza Jr, R Bajorunaite… - Blood, 2003 - ashpublications.org
In this article, we report on 904 patients undergoing transplantation for follicular lymphoma.
A total of 176 (19%) received allogeneic, 131 (14%) received purged autologous, and 597 …

[HTML][HTML] Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—an observational study

A Ip, DA Berry, E Hansen, AH Goy, AL Pecora… - PloS one, 2020 - journals.plos.org
Hydroxychloroquine has been touted as a potential COVID-19 treatment. Tocilizumab, an
inhibitor of IL-6, has also been proposed as a treatment of critically ill patients. In this …

A paradigm for consensus: the University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions

LC Vermeulen, TA Ratko, BL Erstad… - Archives of internal …, 1995 - jamanetwork.com
Objective: To develop contemporary, comprehensive guidelines for the appropriate and
efficient use of albumin, nonprotein colloid, and crystalloid solutions. Design: A systematic …